Paloma Partners’s Enzo Biochem, Inc. ENZ Stock Holding History

Paloma Partners’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-55,350	Closed	-$168K	–	1982
2015 Q2	$168K	Buy	+55,350	New	+$156K	﹤0.01%	1603
2014 Q4	–	Sell	-19,270	Closed	-$99K	–	1413
2014 Q3	$99K	Buy	+19,270	New	+$103K	﹤0.01%	894

Other funds holding ENZ

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

LSVM

Lone Star Value Management Old Greenwich, Connecticut $52.7M AUM 30.18% 1-Year Est. Return

KIA

Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

MAG

Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return

Paloma Partners's ENZ Position: Q3 2015 in Review

Paloma Partners sold out of Enzo Biochem, Inc. (ENZ) in Q3 2015, closing a stake of 55,350 shares — an estimated $168K sold.

Paloma Partners first reported a position in ENZ in Q3 2014 and held it in 2 quarters. The position peaked at $168K in Q2 2015. 82 funds tracked by Wall St. Rank hold ENZ as of Q3 2015.

Paloma Partners reported no remaining Enzo Biochem, Inc. position as of Q3 2015 after selling out during the quarter.
Paloma Partners sold 55,350 Enzo Biochem, Inc. shares in Q3 2015, an estimated $168K.
Paloma Partners first reported a position in Enzo Biochem, Inc. in Q3 2014 and held it in 2 quarters.
Paloma Partners's Enzo Biochem, Inc. position peaked at $168K in Q2 2015.
82 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q3 2015.

Based on Paloma Partners's 13F filing for Q3 2015, filed 16 Nov 2015.